BBI Stock Doubles After Positive Data for Sofpironium Bromide
In a fresh development that has come as a big boost BBI stock, Brickell Biotech Inc (NASDAQ:BBI) released positive results from the Phase 2b clinical trial of one of its products. The product in question ... [Read]
MITO Stock Soars on Impressive Elamipretide Data
Stealth BioTherapeutics Corp (NASDAQ:MITO) made a major announcement today regarding elamipretide, which resulted in a highly impressive rally in MITO stock this morning. A natural history study of elamipretide has revealed that subcutaneous injections of ... [Read]
GNPX Stock is Up 900% in a Month, But Why the Sudden Growth?
Over the past month, thinly traded penny stock Genprex Inc (NASDAQ:GNPX) has managed to come into sharp focus in the market. GNPX stock has rallied by as much as 900% during the period and has ... [Read]
ADXS Stock Jumps: Partners with Personalis for ADXS-503 Program
In a new development, which has come as a significant boost for ADXS stock, Advaxis, Inc. (NASDAQ:ADXS) announced that it has reached an agreement with Personalis Inc (NASDAQ:PSNL) for a collaboration deal. The company announced ... [Read]
VTVT Stock Hits New High After Positive TTP399 Data
Positive results from clinical trials often work as a positive trigger for pharmaceutical or biotech stocks, and that is what happened with VTVT stock this morning. The micro-cap stock soared on high trading volumes today ... [Read]
VVUS Stock Jumps 70% on FDA Nod for New Formulation of Pancreaze
When biotech or pharmaceutical companies win approvals from the United States Food and Drug Administration, the stock prices almost always go up, and that is what happened with VVUS stock this morning. VVUS is normally ... [Read]
BCRX Stock Soars After Filing Treatment for Japanese Approval
BCRX stock is soaring today after BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it had filed for regulatory approval in Japan for Berotralstat, a prophylactic treatment of hereditary angioedema (HAE). BioCryst has already received Orphan Drug and ... [Read]
HEPA Stock Rockets 33% on Positive NASH Treatment Data
In the world of pharmaceutical stocks, positive data for medicine in the pipeline leads to a spike in the company’s stock price on most occasions, and that is what happened with the HEPA stock on ... [Read]
GNPX Stock Quadruples on FDA Fast Track Status for Oncoprex Therapy
In a new development that has come as a significant boost for GNPX stock, Genprex Inc (NASDAQ:GNPX) today announced that one of its products has been awarded a fast track designation by the United States ... [Read]
NVAX Stock Soars 44% in a Week on Bullish Sentiment
When a pharmaceutical or biotech company manages to get a highly positive update with regards to one of its products in development, then the stock price generally moves in the right direction. That is what ... [Read]